CIK 0001213037 · Non-accelerated filer<br>Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272004382
- Phone
- 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-16 | Armitage James O Director | Purchase | +13,000 | $1.56 | $20K | 13,000 |
| 2022-09-16 | Levine James E. Chief Financial Officer | Purchase | +30,000 | $1.56 | $47K | 60,000 |
| 2022-09-15 | TANNENBAUM RENEE P Director | Purchase | +6,400 | $1.72 | $11K | 6,400 |
| 2022-09-15 | TANNENBAUM RENEE P Director | Purchase | +3,600 | $1.72 | $6K | 10,000 |
| 2022-09-15 | PACE GARY W Director | Purchase | +150,000 | $1.71 | $257K | 644,811 |
| 2022-07-05 | White Lale Director | Option exercise | +28,858 | $2.60 | $75K | 98,788 |
| 2022-07-05 | White Lale Director | Option exercise · Stock Options | −28,858 | $2.60 | $75K | 60,716 |
| 2022-06-09 | BRANCACCIO JOHN P Former Director | Other acquisition · Stock Options | +26,800 | 125,317 | ||
| 2022-06-09 | BRANCACCIO JOHN P Former Director | Other acquisition · Stock Options | +22,000 | 125,317 | ||
| 2022-06-09 | BRANCACCIO JOHN P Former Director | Other acquisition · Stock Options | +28,858 | 125,317 | ||
| 2022-06-09 | BRANCACCIO JOHN P Former Director | Other acquisition · Stock Options | +44,734 | 125,317 | ||
| 2022-06-09 | BRANCACCIO JOHN P Former Director | Other acquisition · Stock Options | +755 | 125,317 | ||
| 2022-06-09 | BRANCACCIO JOHN P Former Director | Other acquisition · Stock Options | +530 | 125,317 | ||
| 2022-06-09 | BRANCACCIO JOHN P Former Director | Other acquisition · Stock Options | +223 | 125,317 | ||
| 2022-06-09 | BRANCACCIO JOHN P Former Director | Other acquisition · Stock Options | +223 | 125,317 | ||
| 2022-06-09 | BRANCACCIO JOHN P Former Director | Other acquisition · Stock Options | +195 | 125,317 | ||
| 2022-03-09 | PACE GARY W Director | Grant or award · Stock Options | +26,800 | 89,574 | ||
| 2022-03-09 | White Lale Director | Grant or award · Stock Options | +26,800 | 89,574 | ||
| 2022-03-09 | TANNENBAUM RENEE P Director | Grant or award · Stock Options | +26,800 | 70,801 | ||
| 2022-03-09 | Ruffner Katherine L Chief Medical Officer | Grant or award · Stock Options | +170,016 | 370,016 |
Page 4 of 8 · 144 trades